47 results
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
that the Shares are subject to the aforementioned restrictions in satisfaction of the notice requirement set forth in Section 151(f) of the Delaware …
“restricted securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
that the Shares are subject to the aforementioned restrictions in satisfaction of the notice requirement set forth in Section 151(f) of the Delaware General … thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701 provides that if the issuer qualifies under Rule 701
S-1
EX-10.5
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
that the Shares are subject to the aforementioned restrictions in satisfaction of the notice requirement set forth in Section 151(f) of the Delaware General … securities” acquired, directly or indirectly from the issuer thereof, in a non-public offering subject to the satisfaction of certain conditions. Rule 701
S-3
EX-4.4
ALGS
Aligos Therapeutics Inc
4 Nov 21
Shelf registration
4:57pm
. SATISFACTION AND DISCHARGE; DEFEASANCE
Section 8.1.
Satisfaction and Discharge of Indenture
Section 8.2.
Application of Trust Funds; Indemnification … .
Satisfaction of Sinking Fund Payments with Securities
Section 11.3.
Redemption of Securities for Sinking Fund
iii
ALIGOS THERAPEUTICS, INC
S-1/A
EX-10.6
ALGS
Aligos Therapeutics Inc
9 Oct 20
IPO registration (amended)
5:26pm
the Participant has made such arrangements as the Company may require for the satisfaction of any Tax Liability that may arise in connection with the exercise … , and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the Company in satisfaction of the Option exercise price; provided
S-1
EX-3.1
8kk193 q2
25 Sep 20
IPO registration
5:27pm
S-1/A
EX-3.2
onspigx09dnnnxasb
9 Oct 20
IPO registration (amended)
5:26pm
S-1
EX-10.2
7ydkvfn
25 Sep 20
IPO registration
5:27pm
S-1
EX-10.1
4oamdhhet96y5n75
25 Sep 20
IPO registration
5:27pm
10-K
EX-4.3
9zb2cn2bi
23 Mar 21
Annual report
4:26pm
CORRESP
swbo5u07f4xvyu
22 Dec 22
Correspondence with SEC
12:00am
S-1/A
EX-10.6
o6g02nm 05
9 Oct 20
IPO registration (amended)
5:26pm
424B3
bkjt4drdjk28dy
28 Nov 23
Prospectus supplement
4:01pm
S-3
EX-1.2
42p0o6u 0pd
4 Nov 21
Shelf registration
4:57pm
8-K
EX-4.1
upp992ub12 5k3u
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-4.2
pwg08q4h int2
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
S-1
EX-10.5
937x96abd jg3l549
25 Sep 20
IPO registration
5:27pm